Q4 2024 |
101 |
$5.75B |
+$986M |
-$1.03B |
-$45.7M |
SONY, LYG, SAN, GSK, PHG
|
Restatement |
2/13/2025, 01:54 PM |
Q3 2024 |
102 |
$6.2B |
+$159M |
-$408M |
-$249M |
PHG, LYG, SAN, SONY, GSK
|
13F-HR |
11/5/2024, 11:55 AM |
Q2 2024 |
98 |
$6.1B |
+$541M |
-$1.41B |
-$866M |
PHG, LYG, SAN, SONY, GSK
|
13F-HR |
8/12/2024, 07:46 AM |
Q1 2024 |
92 |
$6.67B |
+$1.16B |
-$367M |
+$798M |
SAN, TSM, GSK, LYG, BP
|
13F-HR |
5/7/2024, 09:59 AM |
Q4 2023 |
91 |
$5.47B |
+$1.38B |
-$395M |
+$986M |
BAP, SAN, SONY, MSFT, DLTR
|
13F-HR |
2/13/2024, 09:00 AM |
Q3 2023 |
87 |
$4.18B |
+$260M |
-$714M |
-$454M |
BAP, PBR, ATHM, ABBV, MSFT
|
13F-HR |
11/6/2023, 09:20 AM |
Q2 2023 |
95 |
$5B |
+$509M |
-$329M |
+$180M |
TRP, BAP, MSFT, META, PBR
|
Restatement |
9/20/2023, 01:45 PM |
Q1 2023 |
91 |
$4.53B |
+$241M |
-$357M |
-$116M |
BAP, MSFT, ATHM, TRP, META
|
Restatement |
9/20/2023, 03:00 PM |
Q4 2022 |
83 |
$4.27B |
+$350M |
-$260M |
+$89.3M |
BAP, ATHM, BIDU, GOLD, VALE
|
13F-HR |
2/3/2023, 08:58 AM |
Q3 2022 |
77 |
$3.78B |
+$465M |
-$287M |
+$178M |
BAP, BIDU, ATHM, WMT, MSFT
|
13F-HR |
10/21/2022, 12:48 PM |
Q2 2022 |
74 |
$4.05B |
+$394M |
-$227M |
+$167M |
ATHM, BIDU, BAP, ABBV, MSFT
|
13F-HR |
8/9/2022, 12:26 PM |
Q1 2022 |
118 |
$4.36B |
+$330M |
-$990M |
-$660M |
BIDU, BAP, ATHM, MSFT, PGR
|
13F-HR |
5/5/2022, 11:13 AM |
Q4 2021 |
125 |
$4.98B |
+$504M |
-$545M |
-$40.3M |
BIDU, BAP, MSFT, CNC, TSM
|
13F-HR |
2/9/2022, 08:03 AM |
Q3 2021 |
121 |
$4.95B |
+$408M |
-$440M |
-$31.5M |
BIDU, BAP, TSM, ATHM, MSFT
|
13F-HR |
10/27/2021, 11:38 AM |
Q2 2021 |
123 |
$5.24B |
+$750M |
-$213M |
+$537M |
BIDU, TSM, ATHM, BAP, INFY
|
13F-HR |
7/30/2021, 07:17 AM |
Q1 2021 |
117 |
$4.49B |
+$1.03B |
-$715M |
+$312M |
BIDU, TSM, ATHM, INFY, WFC
|
13F-HR |
5/10/2021, 09:53 AM |
Q4 2020 |
106 |
$3.92B |
+$644M |
-$117M |
+$527M |
BIDU, TSM, INFY, BAP, JNJ
|
13F-HR |
2/11/2021, 06:16 AM |
Q3 2020 |
101 |
$2.77B |
+$362M |
-$162M |
+$200M |
BIDU, INFY, TSM, YUMC, GOLD
|
13F-HR |
11/13/2020, 10:33 AM |
Q2 2020 |
103 |
$2.68B |
+$501M |
-$926M |
-$425M |
TSM, BIDU, INFY, NTES, YUMC
|
13F-HR |
8/10/2020, 10:46 AM |
Q1 2020 |
99 |
$2.74B |
+$247M |
-$201M |
+$46.5M |
BABA, NTES, TSM, INFY, JNJ
|
13F-HR |
5/12/2020, 12:47 PM |
Q4 2019 |
112 |
$3.63B |
+$538M |
-$87.1M |
+$451M |
BABA, ERJ, NTES, TSM, INFY
|
13F-HR |
2/6/2020, 09:50 AM |
Q3 2019 |
112 |
$2.91B |
+$336M |
-$344M |
-$7.66M |
BABA, ERJ, TSM, INFY, ITUB
|
13F-HR |
11/4/2019, 09:10 AM |
Q2 2019 |
110 |
$2.96B |
+$210M |
-$113M |
+$97.1M |
ERJ, BABA, ITUB, TSM, JNJ
|
13F-HR |
8/7/2019, 11:45 AM |
Q1 2019 |
113 |
$3.01B |
+$392M |
-$76.2M |
+$316M |
ERJ, BABA, TSM, ITUB, BAP
|
13F-HR |
4/17/2019, 02:17 PM |
Q4 2018 |
114 |
$2.52B |
+$208M |
-$240M |
-$31.9M |
ERJ, TSM, ITUB, BAP, JNJ
|
13F-HR |
1/24/2019, 06:08 AM |
Q3 2018 |
110 |
$2.92B |
+$187M |
-$268M |
-$80.2M |
ERJ, TSM, ITUB, BAP, MSFT
|
13F-HR |
11/1/2018, 01:29 PM |
Q2 2018 |
113 |
$3.05B |
+$124M |
-$200M |
-$76.1M |
ERJ, TSM, ITUB, BAP, MSFT
|
13F-HR |
7/25/2018, 06:44 AM |
Q1 2018 |
118 |
$3.33B |
+$156M |
-$431M |
-$276M |
ERJ, ITUB, TSM, BAP, PHI
|
13F-HR |
5/11/2018, 06:51 AM |
Q4 2017 |
126 |
$3.68B |
+$523M |
-$359M |
+$164M |
ERJ, ITUB, TSM, BAP, PHI
|
13F-HR |
1/18/2018, 09:25 AM |
Q3 2017 |
122 |
$3.5B |
+$667M |
-$280M |
+$387M |
TSM, ERJ, ITUB, BAP, ABEV
|
13F-HR |
11/2/2017, 07:17 AM |
Q2 2017 |
126 |
$3.07B |
+$251M |
-$310M |
-$59.1M |
TSM, BAP, PHI, ABEV, BSMXXXXX
|
13F-HR |
8/2/2017, 10:48 AM |
Q1 2017 |
128 |
$3.16B |
+$462M |
-$273M |
+$189M |
TSM, PHI, BAP, ABEV, BSMXXXXX
|
13F-HR |
4/26/2017, 10:30 AM |
Q4 2016 |
126 |
$3.1B |
+$108M |
-$383M |
-$275M |
BAP, ABT, PHI, TSM, ABEV
|
13F-HR |
2/3/2017, 08:21 AM |
Q3 2016 |
126 |
$3.54B |
+$506M |
-$436M |
+$70.7M |
BAP, ABT, PHI, TSM, ABEV
|
13F-HR |
11/8/2016, 10:03 AM |
Q2 2016 |
124 |
$3.71B |
+$237M |
-$545M |
-$308M |
BAP, ABT, PHIXXXX, BSMXXXXX, TSM
|
13F-HR |
8/1/2016, 12:00 PM |
Q1 2016 |
127 |
$4.03B |
+$575M |
-$397M |
+$178M |
YUM, BAP, ABT, PHIXXXX, BSMXXXXX
|
13F-HR |
5/4/2016, 10:02 AM |
Q4 2015 |
131 |
$4.12B |
+$199M |
-$499M |
-$300M |
MR, YUM, PHIXXXX, BAP, BSMXXXXX
|
13F-HR |
1/13/2016, 09:05 AM |
Q3 2015 |
129 |
$4.3B |
+$295M |
-$773M |
-$478M |
YUM, TEVA, PHIXXXX, MR, BAP
|
13F-HR |
10/20/2015, 09:55 AM |
Q2 2015 |
84 |
$5.49B |
+$224M |
-$405M |
-$181M |
TEVA, YUM, PHIXXXX, MR, BAP
|
13F-HR |
7/27/2015, 11:22 AM |
Q1 2015 |
85 |
$5.78B |
+$239M |
-$231M |
+$7.96M |
TEVA, YUM, PHIXXXX, MR, ENIAY
|
Restatement |
8/10/2015, 10:11 AM |
Q4 2014 |
90 |
$6.21B |
+$411M |
-$576M |
-$165M |
TEVA, YUM, PHIXXXX, BAP, MR
|
13F-HR |
1/27/2015, 11:42 AM |
Q3 2014 |
87 |
$6.57B |
+$151M |
-$537M |
-$386M |
TEVA, YUM, PHIXXXX, BAP, MR
|
13F-HR |
10/22/2014, 09:49 AM |
Q2 2014 |
90 |
$7.12B |
+$446M |
-$521M |
-$74.9M |
TEVA, YUM, PHIXXXX, BAP, VALEP
|
13F-HR |
8/4/2014, 10:33 AM |
Q1 2014 |
88 |
$6.79B |
+$212M |
-$689M |
-$477M |
TEVA, YUM, VALEP, MR, PHIXXXX
|
13F-HR |
4/15/2014, 07:25 AM |
Q4 2013 |
88 |
$7.14B |
|
|
|
TEVA, YUM, MR, VALEP, BSMXXXXX
|
13F-HR |
1/7/2014, 06:43 AM |